Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma.
van der Velden VH, Hoogeveen PG, de Ridder D, Schindler-van der Struijk M, van Zelm MC, Sanders M, Karsch D, Beverloo HB, Lam K, Orfao A, Lugtenburg PJ, Böttcher S, van Dongen JJ, Langerak AW, Kappers-Klunne M, van Lom K. van der Velden VH, et al. Among authors: van dongen jj, van lom k, van zelm mc. Blood. 2014 Jul 17;124(3):412-9. doi: 10.1182/blood-2013-10-533869. Epub 2014 Jun 2. Blood. 2014. PMID: 24891323 Free article.
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells.
van Der Velden VH, te Marvelde JG, Hoogeveen PG, Bernstein ID, Houtsmuller AB, Berger MS, van Dongen JJ. van Der Velden VH, et al. Among authors: van dongen jj. Blood. 2001 May 15;97(10):3197-204. doi: 10.1182/blood.v97.10.3197. Blood. 2001. PMID: 11342449 Free article. Clinical Trial.
Low frequency of reverse transcription polymerase chain reaction-detectable chromosome aberrations in relapsed acute myeloid leukaemia: implications for detection of minimal residual disease.
van der Velden VH, Schoch C, Langerak AW, Schnittger S, Hoogeveen PG, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj. Br J Haematol. 2001 Jun;113(4):1082-3. doi: 10.1046/j.1365-2141.2001.02821-7.x. Br J Haematol. 2001. PMID: 11442511 Free article. No abstract available.
Clearance of maternal leukaemic cells in a neonate.
van der Velden VH, Willemse MJ, Mulder MF, Szczepański T, Langerak AW, Wijkhuijs JM, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj. Br J Haematol. 2001 Jul;114(1):104-6. doi: 10.1046/j.1365-2141.2001.02914.x. Br J Haematol. 2001. PMID: 11472352 Free article.
Minimal residual disease in leukaemia patients.
Szczepański T, Orfão A, van der Velden VH, San Miguel JF, van Dongen JJ. Szczepański T, et al. Among authors: van der velden vh, van dongen jj. Lancet Oncol. 2001 Jul;2(7):409-17. doi: 10.1016/s1470-2045(00)00418-6. Lancet Oncol. 2001. PMID: 11905735 Review.
Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.
van der Velden VH, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj, van der schoot ce, van wering er. Leukemia. 2002 May;16(5):928-36. doi: 10.1038/sj.leu.2402475. Leukemia. 2002. PMID: 11986956
Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH, Jacobs DC, Wijkhuijs AJ, Comans-Bitter WM, Willemse MJ, Hählen K, Kamps WA, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj, van wering er. Leukemia. 2002 Aug;16(8):1432-6. doi: 10.1038/sj.leu.2402636. Leukemia. 2002. PMID: 12145681
250 results